Vaxcyte, Inc. (PCVX) Misses Q3 EPS by 7c

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q3 EPS of ($0.91), $0.07 worse than the analyst estimate of ($0.84).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18